Decision Intelligence Boutique · Saudi Arabia & GCC

We build decision systems healthcare leaders can trust.

HealthElevate provides structured Decision Instruments for executives facing high-stakes, difficult-to-reverse choices: before those choices become irreversible.

Explore Our Instruments Read Our Insights
What We Do

Decision Assurance for High-Stakes Healthcare

We are not a consulting firm, an analytics vendor, or an AI company. HealthElevate operates above vendors and below boards – providing independent analytical judgment through proprietary Decision Instruments when it matters most.

Decision Instruments

A growing suite of proprietary instruments across VBHC readiness, AI governance, population health, reimbursement reform, FWA governance, market access, and more – each delivering a clear Proceed, Delay, or Redesign recommendation.

Independent Analysis

Every engagement is grounded exclusively in publicly available data: vendor-neutral, COI-protected, and designed to withstand board-level scrutiny. Our independence is the value.

Board-Ready Outputs

Every engagement concludes with a structured written brief: section-by-section risk analysis, an explicit Proceed / Delay / Redesign recommendation, and a summary ready for executive or board presentation.

The Saudi Healthcare Decision Environment

Why Decision Rigour Matters Here

Saudi Arabia's healthcare transformation is operating at speed. The decisions being made now – on VBHC contracting, AI deployment, insurance reform, and population health – will shape the system's performance through 2030 and beyond.

SAR 140B
Insurance market growth targeted by the National Insurance Sector Strategy (NISS) through 2030
SAR 3.5B+
Annual preventable claims losses in Saudi healthcare – largely process failures, not fraud
SAR 40–65B
Potential annual savings from successful VBHC implementation by 2035 (PwC estimate)
5.88%
Current AI adoption rate in Saudi hospitals – despite active procurement across the sector
Decision Instruments

One Suite. One Purpose.

Each instrument addresses a specific high-stakes healthcare decision. Every output delivers a structured Proceed / Delay / Redesign recommendation supported by evidence-backed analysis.

VBHC Contract Stress Test
Live
"Are we operationally and financially ready to enter a value-based contract?"
AI Deployment Governance Gate
Live
"Is our AI system safe, explainable, and decision-ready before we scale?"
PHM Readiness Assurance Review
Bespoke Engagement
"Are we ready to launch or scale a population health management programme?"
Provider Revenue Sustainability Stress Test
Bespoke Engagement
"Is our revenue model resilient under payer tightening and DRG transition?"
Regulatory Shock Preparedness Review
Bespoke Engagement
"How exposed are we to regulatory reinterpretation or enforcement tightening?"
+ 7 More Instruments
FWA governance, integrated care, digital health, board decision safety, and more
View all instruments →
Insights

Independent Analysis of Saudi Healthcare Reform

View All Insights
Insurance Reform
The NISS Expansion: What Scaling to 23 Million Beneficiaries Actually Requires
The NISS reimbursement reform, AR-DRG transition, and NPHIES integration arrive simultaneously. Most organisations are preparing for one of three concurrent pressures: not all three at once.
6 min read Read →
AI Governance
AI Deployment in Saudi Healthcare: Why the Governance Gap Is the Real Risk
Saudi Arabia has world-leading AI device regulation. The accountability gap sits at the deployment decision level – and most organisations have not addressed it.
6 min read Read →
VBHC & Contracting
Value-Based Healthcare in Saudi Arabia: The Outcome Measurement Gap
Saudi VBHC contracts are failing in a predictable three-year cycle. Measuring outcomes and contracting on them are not the same discipline.
6 min read Read →
Reimbursement Reform
AR-DRG Adoption in Saudi Arabia: What the Reimbursement Shift Requires from Providers and Insurers
38% of Saudi providers are not yet prepared for DRG coding. The question is not whether to transition: it is whether your organisation can absorb the shift without a cash-flow or pricing crisis in year one.
8 min read Read →
Regulatory Governance
Risk-Based Capital and the Insurance Authority: What Saudi Insurers Must Restructure Before 2027
RBC pilot 2026, mandatory January 2027 – arriving simultaneously with NISS expansion, AR-DRG transition, and a consolidated Insurance Law. The compounded risk for health insurers is the analytical story.
9 min read Read →
Claims Governance
FWA in Saudi Healthcare: Structural Exposure, False Positives, and the True Cost of Misaligned Controls
80 million claims, SAR 25 billion annually. The governance problem is not that fraud is invisible: it is that detection conflates fraud, waste, abuse, and coding error, and the conflation is expensive for everyone.
9 min read Read →
Digital Health Infrastructure
NPHIES: From Compliance Infrastructure to Clinical Intelligence Asset
130 million transactions processed. Most organisations use NPHIES to file claims. The decision to use the data it generates for strategic intelligence is the analytical inflection point of the Saudi reform period.
9 min read Read →
Pharmacy & Drug Cost Governance
PBM Governance and Pharmacy Cost Integrity in Saudi Healthcare
USD 11.6B market growing 9.1% in 2024. SAR 335M in actual generic substitution savings, SAR 228M unrealised. Most Saudi insurers run pharmacy as claims processing. Mature PBM governance is a different discipline.
9 min read Read →
Care Delivery Reform
The Homecare Imperative: How a 40,000 Bed Shortfall Reshapes Saudi Care Delivery
40,000 inpatient bed deficit projected by 2035. 7.1M Saudis aged 65+ by 2050. Homecare is the structural response to a capacity ceiling fixed bed expansion cannot solve. The governance architecture has not yet caught up.
9 min read Read →
Population Health Strategy
From Reactive Claims to Population Health: The Strategic Question Most Saudi Insurers Have Not Yet Answered
73% of Saudi deaths are NCDs. 26.7% of adults have multiple chronic conditions, rising to 62.9% over 65. The CHI mandated a five-condition PHM strategy. The capability gap to act on it is the central commercial question of the reform period.
9 min read Read →
Data Governance & Compliance
The Data Governance Gap: PDPL and the Foundation Under Every Healthcare Analytics Ambition
PDPL fully enforced since September 2024: SAR 5M fines, criminal liability, 48 enforcement decisions. Health data is the most protected category. The analytics agenda and the compliance exposure grow from the same activity.
9 min read Read →
Where to Start

Who We Work With

HealthElevate is built for healthcare leaders who carry decision responsibility. Each role faces a different reform exposure. Each pathway below names the three live diagnostics most relevant for that role today.

CFOs & Chief Actuaries

Capital adequacy under RBC, value-based contract exposure, and pharmacy spend governance ahead of the AR-DRG transition.

→ IA RBC Readiness Gate → VBHC Contract Stress Test → PBM Governance Diagnostic

COOs & Operations Directors

AR-DRG operational transition, NPHIES intelligence maturity, and homecare programme scaling against the capacity ceiling.

→ AR-DRG Transition Readiness → NPHIES Maturity Diagnostic → Homecare Launch Readiness

CMOs & Chief Clinical Officers

Population health management against the CHI five-condition strategy, AI governance, and FWA controls calibrated for the right failure mode.

→ PHM Readiness Diagnostic → AI Deployment Governance Gate → FWA Governance Diagnostic

VBHC & Value-Based Programme Directors

Value-based contract stress testing, AR-DRG operational interaction, and population health as the substantive backbone of value delivery.

→ VBHC Contract Stress Test → AR-DRG Transition Readiness → PHM Readiness Diagnostic

Board Members & Non-Executives

Capital adequacy oversight, FWA governance scrutiny, and population health strategic exposure for the next three regulatory cycles.

→ IA RBC Readiness Gate → FWA Governance Diagnostic → PHM Readiness Diagnostic

National Transformation Leaders

System-level analytical work on NPHIES intelligence, AR-DRG transition coordination, and population health programme scale-up across the network.

→ NPHIES Maturity Diagnostic → PHM Readiness Diagnostic → AR-DRG Transition Readiness
How to Engage

Structured Analytical Support. Precisely Scoped.

Every engagement begins with a focused scoping conversation to confirm the decision context and identify the right instrument. Three tiers are available – from a rapid single-instrument brief to a coordinated programme diagnostic.

All engagements are structured around specific decision contexts, not open-ended retainers. Every tier delivers a written Proceed / Delay / Redesign recommendation with clear scope and defined timeline.

View Engagement Details

Ready to bring rigour to your next critical decision?

Every engagement begins with a focused conversation about your specific decision context. No open-ended retainers. No jargon. Structured analytical support, precisely scoped.

Request a Diagnostic